Skip to main content
Caplight Logo









Nutrigenomix

Nutrigenomix

Private
Toronto, OntarioHealthcare & Life Scienceshttps://nutrigenomix.com

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nutrigenomix operates in Healthcare & Life Sciences and is based in Toronto, Ontario. It was founded in 2011.

Nutrigenomix is a biotechnology company that provides an award-winning panel of genetic tests for personalized nutrition.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nutrigenomix Comparables

Compare Nutrigenomix with similar companies based on industry and business-model similarity.

Nutrigenomix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
3X4 Genetics
84%
Nordic Group
84%
Toolbox Genomics
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nutrigenomix Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Nutrigenomix. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ahmed El-Sohemy

Founder And Chief Science Officer

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 69% MoM, reaching 16.1K.

  • Jul 24, 2026

    Monthly visitors grew 32% MoM, reaching 9.5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Nutrigenomix Filings

Explore SEC and related filing metadata, where available.

Nutrigenomix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nutrigenomix's valuation, stock price, and market status.

Is Nutrigenomix a public or private company?

Nutrigenomix is a private company.

What is the current stock price of Nutrigenomix?

Nutrigenomix is a private company, so its shares have no public market price. Caplight tracks Nutrigenomix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nutrigenomix worth (valuation)?

Valuation information for Nutrigenomix is not publicly available.

Can I buy Nutrigenomix stock?

Nutrigenomix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nutrigenomix's last funding round?

Funding round information for Nutrigenomix is not publicly available.

Who are the main investors in Nutrigenomix?

Investor information for Nutrigenomix is not publicly disclosed.

Will Nutrigenomix IPO soon?

No public IPO plans have been announced for Nutrigenomix.

How can I track Nutrigenomix secondary market activity?

Caplight tracks bids, offers, and trades in Nutrigenomix's shares on secondary markets.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range15
Year Founded2011
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?